Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - HEALY JAMES
Last Updated 
12-Nov-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

HEALY JAMES: Declared Holdings
Company/RelationshipReportedShares  Ownership
COHERUS BIOSCIENCES, INC.
Director
NasdaqGM:CHRS
(historical quotes, profile, other insiders)
12-Nov-14
12-Nov-14
47
   2,557,759
2,557,806
  Direct
  Indirect  
  Total
Hyperion Therapeutics, Inc.
Director
NasdaqGS:HPTX
(historical quotes, profile, other insiders)
27-May-14
4-Jun-14
14,472
   1,939,474
1,953,946
  Direct
  Indirect  
  Total
InterMune, Inc.
Director
NasdaqGS:ITMN
(historical quotes, SEC, other insiders)
29-Sep-140  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
12-Nov-14 *425,926CHRS Purchase at $13.50 per share.
(Cost of $5,750,001)
12-Nov-14 *1,996,860CHRS Acquisition (Non Open Market)
12-Nov-14 47CHRS Acquisition (Non Open Market)
6-Nov-14 *134,973CHRS Statement of Ownership
29-Sep-14 13,549ITMN Disposition (Non Open Market) at $74 per share.
(Value of $1,002,626)
4-Jun-14 *417,747HPTX Sale at $27.70 per share.
(Proceeds of $11,571,591)
30-May-14 3,000ITMN Option Exercise at $0 per share.
27-May-14 2,617HPTX Acquisition (Non Open Market) at $0 per share.
4-Mar-14 *23,625HPTX Automatic Sale at $30.02 per share.
(Proceeds of $709,222)
3-Mar-14 *23,625HPTX Acquisition (Non Open Market) at $0 per share.
3-Mar-14 *590,000HPTX Automatic Sale at $0 per share.
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?